background
glucocorticoid
wide
use
treatment
variou
pulmonari
inflammatori
diseas
also
often
accompani
signific
advers
reaction
publish
guidelin
point
low
dose
short
durat
system
glucocorticoid
therapi
may
consid
patient
rapidli
progress
evid
still
limit
comprehens
search
electron
databas
supplement
screen
conduct
manual
search
includ
rct
cohort
studi
evalu
effect
safeti
glucocorticoid
children
adult
sar
mer
conduct
metaanalys
main
indic
identifi
studi
search
retriev
studi
includ
one
rct
cohort
studi
total
patient
adult
use
system
glucocorticoid
reduc
mortal
ci
durat
lung
inflamm
day
ci
signific
reduct
found
durat
fever
day
ci
patient
sar
glucocorticoid
also
reduc
mortal
ci
durat
fever
day
ci
durat
lung
inflamm
absorpt
right
reserv
reus
allow
without
permiss
day
ci
use
system
glucocorticoid
therapi
prolong
durat
hospit
stay
patient
sar
mer
conclus
glucocorticoid
therapi
found
reduc
durat
fever
mortal
durat
hospit
lung
inflamm
absorpt
longterm
use
highdos
glucocorticoid
increas
risk
advers
reaction
coinfect
routin
use
system
glucocorticoid
patient
recommend
keyword
glucocorticoid
metaanalysi
conflict
opinion
use
glucocorticoid
treat
patient
suggest
current
clinic
evid
support
use
glucocorticoid
may
caus
sever
side
effect
howev
clinician
front
line
epidem
propos
shortterm
glucocorticoid
therapi
small
medium
dose
could
benefici
patient
sever
condit
current
guidelin
also
inconsist
use
glucocorticoid
guidelin
suggest
tri
shortterm
therapi
medium
small
dose
glucocorticoid
patient
rapid
sever
diseas
progress
accord
guidelin
glucocorticoid
use
clinic
trial
condit
effect
evid
relat
glucocorticoid
treat
still
lack
therefor
purpos
studi
systemat
retriev
summar
current
evid
effect
safeti
glucocorticoid
therapi
patient
aim
provid
best
decisionmak
basi
prevent
control
epidem
two
experienc
librarian
search
follow
databas
januari
march
cochran
librari
medlin
via
pubm
embas
web
scienc
cbm
china
biolog
medicin
cnki
china
nation
knowledg
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
infrastructur
wanfang
data
use
follow
search
novel
coronaviru
wuhan
coronaviru
novel
coronaviru
wuhan
seafood
market
pneumonia
viru
wuhan
viru
mer
sar
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
coronaviru
influenza
adren
cortex
hormon
betamethason
valer
glucocorticoid
methylprednisolon
cortison
dexamethason
cortodoxon
hydrocortison
also
search
clinic
trial
registri
platform
world
health
organ
clinic
trial
registri
platform
us
nation
institut
health
trial
regist
intern
standard
random
control
trial
number
isrctn
regist
googl
scholar
http
scholargooglenl
preprint
platform
biorxiv
http
wwwbiorxivorg
medrxiv
http
wwwmedrxivorg
ssrn
http
wwwssrncomindexcfmen
addit
search
refer
list
identifi
systemat
review
find
potenti
studi
supplement
screen
googl
scholar
conduct
manual
search
everi
day
submiss
search
strategi
construct
assist
specialist
inform
retriev
detail
search
strategi
found
supplementari
materi
includ
studi
glucocorticoid
therapi
patient
diagnos
sar
mer
without
restrict
diagnost
criteria
includ
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
random
control
trial
rct
cohort
studi
compar
glucocorticoid
therapi
versu
placebo
compar
combin
glucocorticoid
symptomat
treatment
symptomat
treatment
alon
primari
outcom
interest
mortal
secondari
outcom
includ
durat
lung
inflamm
absorpt
durat
hospit
stay
durat
fever
advers
effect
like
coinfect
bacteri
fungal
infect
kaliopenia
osteonecrosi
femor
head
onfh
chines
studi
could
retriev
full
text
essenti
data
miss
reason
exclus
inelig
studi
record
process
studi
select
document
use
prisma
flow
diagram
elimin
duplic
two
research
lu
l
huang
independ
screen
literatur
two
step
use
endnot
softwar
first
step
titl
abstract
screen
use
predefin
criteria
exclud
irrelev
articl
second
step
fulltext
potenti
elig
unclear
studi
review
decid
final
inclus
disagr
discuss
solv
third
research
q
shi
reason
exclus
inelig
studi
record
process
studi
select
document
use
prisma
flow
diagram
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
two
research
lu
q
zhou
independ
extract
data
inform
includ
studi
use
standard
data
collect
form
extract
data
includ
basic
inform
first
author
public
year
type
studi
design
particip
diseas
sever
diseas
age
distribut
total
number
patient
detail
intervent
control
group
type
dosag
treatment
cours
glucocorticoid
therapi
outcom
dichotom
data
abstract
number
event
total
number
patient
per
group
continu
data
abstract
mean
standard
deviat
sd
total
number
patient
per
group
data
miss
report
unus
way
report
find
descript
two
research
lu
zhao
independ
assess
potenti
bia
includ
studi
discrep
resolv
discuss
consult
third
research
q
shi
assess
risk
bia
rct
use
cochran
riskofbia
tool
consist
seven
domain
random
sequenc
gener
alloc
conceal
blind
particip
personnel
blind
outcom
assess
incomplet
outcom
data
select
outcom
report
bia
domain
grade
low
unclear
high
cohort
studi
use
newcastleottawa
scale
no
contain
eight
domain
repres
exposur
cohort
select
nonexposur
cohort
determin
exposur
outcom
event
occur
studi
initi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
compar
cohort
base
design
analysi
assess
outcom
event
adequaci
followup
time
complet
followup
two
research
zhou
q
shi
q
assess
qualiti
evid
independ
use
grade
recommend
assess
develop
evalu
grade
tool
produc
summari
find
tabl
use
gradepro
softwar
qualiti
evid
downgrad
base
five
factor
studi
limit
consist
effect
imprecis
indirect
public
bia
upgrad
base
three
factor
larg
magnitud
effect
doserespons
relat
plausibl
confound
bias
qualiti
evid
outcom
classifi
high
moder
low
low
conduct
metaanalys
use
stata
softwar
stata
corp
llc
dichotom
data
calcul
risk
ratio
rr
confid
interv
ci
continu
data
calcul
weight
mean
differ
wmd
ci
miss
data
dealt
accord
cochran
handbook
systemat
review
intervent
clinic
methodolog
heterogen
studi
design
characterist
particip
intervent
outcom
measur
expect
use
randomeffect
model
twosid
p
valu
consid
statist
signific
statist
heterogen
assess
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
statist
indic
substanti
heterogen
detect
heterogen
perform
subgroup
analys
sever
diseas
age
patient
also
consid
sensit
analys
one
studi
exclud
time
egger
test
use
assess
public
bia
comparison
present
name
first
author
year
public
public
health
emerg
intern
concern
situat
evolv
rapidli
studi
regist
order
speed
process
rapid
review
identifi
public
studi
one
rct
cohort
studi
met
inclus
criteria
includ
literatur
screen
process
shown
figur
one
studi
includ
adult
patient
sever
mer
studi
includ
patient
sar
remain
five
studi
patient
tabl
due
insuffici
repres
followup
time
three
articl
score
higher
six
nine
point
methodolog
qualiti
includ
cohort
studi
poor
risk
bia
includ
rct
unclear
unclear
risk
select
bia
detect
bia
report
bia
tabl
tabl
mortal
assess
thirteen
cohort
studi
four
eight
sar
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
one
sever
mer
total
patient
use
system
glucocorticoid
reduc
risk
death
ci
sar
patient
ci
subgroup
analys
show
glucocorticoid
also
reduc
risk
death
sever
case
sar
ci
adult
ci
mild
case
sar
glucocorticoid
even
increas
risk
death
ci
adult
patient
mer
use
glucocorticoid
increas
mortal
ci
five
cohort
studi
total
patient
assess
durat
fever
one
studi
sar
four
studi
patient
durat
fever
significantli
lower
patient
receiv
glucocorticoid
treatment
patient
receiv
glucocorticoid
treatment
ci
sar
patient
differ
ci
subgroup
analysi
show
glucocorticoid
use
shorten
durat
fever
neither
patient
sever
sar
ci
patient
mild
sar
ci
figur
figur
three
cohort
studi
assess
durat
lung
inflamm
absorpt
patient
one
studi
sar
two
studi
differ
patient
receiv
receiv
glucocorticoid
treatment
found
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
neither
ci
sar
ci
patient
subgroup
analys
show
use
glucocorticoid
shorten
absorpt
time
lung
inflamm
patient
sever
sar
regardless
sever
ci
mild
sar
ci
figur
figur
five
cohort
studi
one
three
sar
one
sever
mer
total
patient
assess
durat
hospit
stay
figur
five
cohort
studi
total
patient
assess
advers
outcom
patient
sar
glucocorticoid
use
increas
risk
coinfect
bacteri
fungal
ci
mod
ci
acut
respiratori
distress
syndrom
ard
ci
signific
associ
dic
hypokalemia
hypocalcemia
onfh
found
figur
qualiti
evid
result
mortal
sar
studi
low
qualiti
mer
studi
low
qualiti
tabl
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
heterogen
among
studi
sar
assess
mortal
signific
heterogen
studi
mortal
sar
patient
reduc
subgroup
analysi
sever
case
subgroup
analysi
adult
therefor
diseas
sever
age
probabl
main
sourc
heterogen
metaanalysi
mortal
conduct
sensit
analysi
sar
mortal
omit
one
studi
time
two
studi
signific
impact
result
metaanalysi
figur
dose
glucocorticoid
differ
studi
yam
et
al
studi
high
heterogen
metaanalysi
mortal
may
least
partli
caus
differ
dose
assess
public
bia
eight
studi
sar
mortal
egger
regress
test
show
public
bia
unlik
figur
studi
identifi
direct
evid
clinic
efficaci
glucocorticoid
therapi
five
differ
outcom
adult
evid
low
lowqual
show
glucocorticoid
therapi
significantli
reduc
durat
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
fever
risk
death
lung
inflamm
absorpt
patient
sar
addit
glucocorticoid
therapi
may
even
prolong
durat
hospit
longterm
use
highdos
glucocorticoid
increas
risk
advers
reaction
infect
osteonecrosi
found
moderatequ
evid
patient
mild
sar
glucocorticoid
may
associ
threefold
increas
risk
death
system
glucocorticoid
highli
effect
antiinflammatori
drug
use
infect
remain
controversi
case
seri
children
hubei
report
systemat
glucocorticoid
dose
mgkg
given
two
includ
critic
case
combin
invas
mechan
ventil
intraven
immunoglobulin
children
symptom
admiss
allevi
although
one
partli
recent
cohort
studi
jama
intern
medicin
report
among
patient
ard
treatment
methylprednisolon
decreas
risk
death
result
compar
publish
systemat
review
glucocorticoid
therapi
sever
pneumonia
recent
rapid
review
treatment
show
controversi
evid
use
corticosteroid
could
give
suggest
use
corticosteroid
due
lack
quantit
synthesi
systemat
review
cover
vitro
studi
sar
sar
human
diseas
ard
found
includ
studi
inconclus
remain
four
found
glucocorticoid
harm
recent
systemat
review
influenza
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
pneumonia
show
glucocorticoid
therapi
increas
risk
death
ci
length
icu
stay
day
ci
risk
secondari
infect
ci
metaanalysi
sar
show
incid
osteonecrosi
increas
dose
system
glucocorticoid
summari
rr
osteonecrosi
ci
retrospect
studi
shown
glucocorticoid
given
patient
patient
sever
diseas
high
risk
therapi
current
misus
summari
current
research
evid
support
routin
use
system
glucocorticoid
patient
tend
less
sever
children
adult
use
system
glucocorticoid
particular
recommend
children
knowledg
first
comprehens
systemat
review
effect
safeti
glucocorticoid
therapi
patient
use
data
studi
consid
moment
best
evid
decisionmak
topic
conduct
metaanalys
quantit
synthes
find
includ
studi
object
evalu
current
research
evid
studi
also
sever
limit
found
limit
direct
evid
system
glucocorticoid
therapi
use
indirect
evid
sar
mer
epidem
also
could
conduct
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
subgroup
analys
accord
dose
type
glucocorticoid
small
number
studi
conclus
glucocorticoid
therapi
may
increas
risk
death
patient
coronaviru
infect
mild
symptom
found
associ
glucocorticoid
mortal
patient
sever
symptom
context
clinic
trial
low
dose
system
glucocorticoid
therapi
short
durat
may
accept
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
thank
jann
estil
institut
global
health
univers
geneva
provid
guidanc
comment
review
thank
author
wonder
collabor
conflict
interest
author
conflict
interest
declar
apr
avail
onlin
http
character
pandem
march
internet
world
health
organ
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
downgrad
one
level
sampl
size
less
optim
inform
sampl
oi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
fulltext
articl
assess
elig
n
studi
includ
quantit
synthesi
metaanalysi
n
rct
cohort
studi
fulltext
articl
exclud
n
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
ding
subtot
isquar
p
ni
subtot
isquar
p
id
studi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
subtot
isquar
p
id
studi
sd
treatment
n
mean
weight
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
lim
embas
cochran
mesh
descriptor
middl
east
respiratori
syndrom
coronaviru
explod
tree
mesh
descriptor
sever
acut
respiratori
syndrom
explod
tree
mesh
descriptor
sar
viru
explod
tree
ti
ab
kw
ti
ab
kw
novel
coronaviru
ti
ab
kw
coronaviru
ti
ab
kw
novel
cov
ti
ab
kw
ti
ab
kw
ti
ab
kw
coronaviru
ti
ab
kw
coronaviru
diseas
ti
ab
kw
covid
ti
ab
kw
wuhancov
ti
ab
kw
wuhan
coronaviru
ti
ab
kw
wuhan
seafood
market
pneumonia
viru
ti
ab
kw
middl
east
respiratori
syndrom
ti
ab
kw
mer
ti
ab
kw
merscov
ti
ab
kw
sever
acut
respiratori
syndrom
ti
ab
kw
sar
ti
ab
kw
sarscov
ti
ab
kw
sarsrel
ti
ab
kw
sarsassoci
ti
ab
kw
descriptor
glucocorticoid
explod
tree
descriptor
methylprednisolon
explod
tree
descriptor
cortison
explod
tree
descriptor
dexamethason
explod
tree
descriptor
prednison
explod
tree
descriptor
budesonid
explod
tree
descriptor
betamethason
explod
tree
adren
cortex
hormon
ti
ab
kw
glucocorticoid
ti
ab
kw
methylprednisolon
ti
ab
kw
cortison
ti
ab
kw
dexamethason
ti
ab
kw
prednison
ti
ab
kw
budesonid
ti
ab
kw
beclomethason
ti
ab
kw
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
http
